Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy

The study aims to Compare the diagnostic accuracy of the Michigan Neuropathy Screening Instrument (MNSI) (using MNS questionnaire, ,Inspection, vibratory sensation, Ankle reflexes Exam, 10 g monofilament needle examination), routine NCS, and the U/S of the median, posterior tibial, and sural nerves in identifying diabetic peripheral neuropathy in patients recently diagnosed with type 2 diabetes.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Diabetic Polyneuropathy Diabetes Complications Diabetes Mellitus Diabetic Neuropathies Endocrine System Diseases Nervous System Diseases Neuromuscular Diseases Peripheral Nervous System Diseases

Age range

33 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of medecine Sohag university

Sohag, Egypt

Location status: Recruiting

Location contact

Reda Khalil, Resident

CONTACT

[email protected]

0102 006 5913

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

ü Age: 30-55 y

ü Type of diabetes: Type 2

ü Duration of diabetes: Within 1Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria

Exclusion criteria

Patients who had known conditions that could present with neuropathy such as hereditary sensory neuropathy, vitamin B12 or folate deficiency, paraneoplastic conditions, autoimmune diseases, uremia, hypothyroidism, and ethanol abuse.

Treatment and study plan

Primary outcomes

Early detection of Diabetic Neuropathy

Time frame: Searching in patients diagnosed within 1 year or less

Utilizing the Michigan Neuropathy Screening Instrument, routine nerve conduction study, and nerve ultrasound for early detection of Diabetic Neuropathy

Study contacts

Contact information is provided by the study sponsor or research team.

Reda Khalaf Allah Khalil, Resident

CONTACT

[email protected]

0102 006 5913

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Utilizing the Michigan Neuropathy Screening Instrument, Routine Nerve Conduction Study (NCS), and Nerve Ultrasound for Early Detection of Diabetic Neuropathy

Important dates

Study start: 2023
Primary completion: 2025
Study completion: 2025
First posted: Jul 23, 2024
Registry last updated: Jul 30, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting